Medicare AdvantageCoverageMedium impact
MA07.050n, Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies
Independence Blue Cross·Neurology, PM&R (Physical Medicine & Rehab), Orthopedics +2 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.050n for Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies has been reissued with an effective date of April 1, 2026. This is a policy reissuance rather than new content, but billing teams should review for any updated requirements or coverage changes.
Action Required
By March 31, 2026: Billing team must review the complete reissued policy MA07.050n at the source URL to identify any changes to EMG/NCS billing requirements, coverage criteria, or documentation standards. Update billing protocols and staff training materials accordingly for Medicare Advantage plans.